Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00826748 · ClinicalTrials.gov registry record · Phase 4
Effect of Inhaled Steroids on Gene Expression in the Lungs - 2
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT00826748 is a Phase 4 study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 24 participants.
The verdict
NCT00826748, a Phase 4 study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effect of inhaled beclomethasone (an inhaled corticosteroid) on the pattern of the lung airway epithelium and alveolar macrophages gene expression of healthy smokers. We hypothesize that the administration of beclomethasone will result in reversibility of some of the airway epithelium and alveolar macrophage gene expression changes induced by cigarette smoking.
Interventions
- DRUG Beclomethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2010-11 |
| Est. Completion | 2014-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00826748
The ClinicalTrials.gov registry entry for NCT00826748 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Beclomethasone is the first listed.
NCT00826748 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00826748 about?
NCT00826748 is a clinical study titled "Effect of Inhaled Steroids on Gene Expression in the Lungs - 2". The purpose of this study is to assess the effect of inhaled beclomethasone (an inhaled corticosteroid) on the pattern of the lung airway epithelium and alveolar macrophages gene expression of healthy smokers. We hypothesize that the administration of beclomethasone will result in reversibility of s...
What is the current status of trial NCT00826748?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2010-11. Estimated completion is 2014-12.
What interventions are being tested in trial NCT00826748?
The interventions under investigation include: Beclomethasone (DRUG).
Who is sponsoring clinical trial NCT00826748?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.